The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, multi-center, open-label, dose-escalation and dose expansion study of CBP-1018, a bi-ligand-drug conjugate, in patients with heavily treated advanced solid tumors.
 
Kaiwen Li
No Relationships to Disclose
 
Junyan Wu
No Relationships to Disclose
 
Suiwen Ye
No Relationships to Disclose
 
Yanqiong Liu
No Relationships to Disclose
 
Hao Huang
No Relationships to Disclose
 
Fan Fan
No Relationships to Disclose
 
Yiming Lai
No Relationships to Disclose
 
Suili Zhuang
No Relationships to Disclose
 
Liyan Zhou
No Relationships to Disclose
 
Robert Huang
Employment - Coherent Biopharma
Stock and Other Ownership Interests - Coherent Biopharma
Consulting or Advisory Role - Coherent Biopharma
Research Funding - Coherent Biopharma
Patents, Royalties, Other Intellectual Property - Coherent Biopharma
Travel, Accommodations, Expenses - Coherent Biopharma
Other Relationship - Coherent Biopharma
 
Yan Teng
Employment - Coherent BioPharma (Suzhou) Co.,Ltd
Leadership - Coherent BioPharma (Suzhou) Co.,Ltd
Stock and Other Ownership Interests - Coherent BioPharma (Suzhou) Co.,Ltd
Honoraria - Coherent BioPharma (Suzhou) Co.,Ltd
Travel, Accommodations, Expenses - Coherent BioPharma (Suzhou) Co.,Ltd
 
Xiaoyan Chai
Employment - Coherent BioPharma (Suzhou) Co.,Ltd
Travel, Accommodations, Expenses - Coherent BioPharma (Suzhou) Co.,Ltd
 
Yehui Shi
No Relationships to Disclose
 
Hai Huang
No Relationships to Disclose